Strikingly, the stroke work and plPwr were normalized (Fig. 4k,l), indicating that Loxl2 inhibition prevents stress-induced systolic abnormalities and restores cardiac contractile function to the sham control level. This evidence concerns the gene LOXL2 and Stroke.